newsfilter
← Latest News
Business Wire·

Veradermics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

MANE
  • Veradermics, Inc. (NYSE: MANE) closed an upsized initial public offering of 17,339,294 common stock shares at $17.00 per share.
  • The offering included 2,261,647 shares sold via the full exercise of the underwriters' option.
  • Gross proceeds from the offering totaled approximately $294.8 million before deducting underwriting discounts, commissions, & estimated expenses.
  • All shares in the offering were sold by Veradermics.
  • Trading for Veradermics shares commenced on the New York Stock Exchange on February 4, 2026, under the ticker symbol "MANE".
  • Jefferies, Leerink Partners, Citigroup, & Cantor served as joint book-running managers for the offering.
  • Registration statements for the shares were filed with the SEC & are effective.
  • Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company focused on aesthetic & dermatological conditions.
  • The company's lead program, VDPHL01, is an oral, non-hormonal, extended-release formulation of minoxidil designed to treat pattern hair loss in men & women.
  • VDPHL01 aims to maximize hair restoration benefits while minimizing cardiac risks associated with traditional minoxidil.